Cite
Olson SM, Newhams MM, Halasa NB, et al. Effectiveness of BNT162b2 Vaccine against Critical Covid-19 in Adolescents. N Engl J Med. 2022;doi: 10.1056/NEJMoa2117995.
Olson, S. M., Newhams, M. M., Halasa, N. B., Price, A. M., Boom, J. A., Sahni, L. C., Pannaraj, P. S., Irby, K., Walker, T. C., Schwartz, S. P., Maddux, A. B., Mack, E. H., Bradford, T. T., Schuster, J. E., Nofziger, R. A., Cameron, M. A., Chiotos, K., Cullimore, M. L., Gertz, S. J., Levy, E. R., Kong, M., Cvijanovich, N. Z., Staat, M. A., Kamidani, S., Chatani, B. M., Bhumbra, S. S., Bline, K. E., Gaspers, M. G., Hobbs, C. V., Heidemann, S. M., Maamari, M., Flori, H. R., Hume, J. R., Zinter, M. S., Michelson, K. N., Zambrano, L. D., Campbell, A. P., Patel, M. M., Randolph, A. G. (2022). Effectiveness of BNT162b2 Vaccine against Critical Covid-19 in Adolescents. The New England journal of medicine, . https://doi.org/10.1056/NEJMoa2117995
Olson, Samantha M, et al. "Effectiveness of BNT162b2 Vaccine against Critical Covid-19 in Adolescents." The New England journal of medicine vol. (2022). doi: https://doi.org/10.1056/NEJMoa2117995
Olson SM, Newhams MM, Halasa NB, Price AM, Boom JA, Sahni LC, Pannaraj PS, Irby K, Walker TC, Schwartz SP, Maddux AB, Mack EH, Bradford TT, Schuster JE, Nofziger RA, Cameron MA, Chiotos K, Cullimore ML, Gertz SJ, Levy ER, Kong M, Cvijanovich NZ, Staat MA, Kamidani S, Chatani BM, Bhumbra SS, Bline KE, Gaspers MG, Hobbs CV, Heidemann SM, Maamari M, Flori HR, Hume JR, Zinter MS, Michelson KN, Zambrano LD, Campbell AP, Patel MM, Randolph AG. Effectiveness of BNT162b2 Vaccine against Critical Covid-19 in Adolescents. N Engl J Med. 2022 Jan 12; doi: 10.1056/NEJMoa2117995. Epub 2022 Jan 12. PMID: 35021004.
Copy
Download .nbib